Magnetar Financial’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-11,918
Closed -$3.28M – 1435
2025
Q4
$3.28M Buy
+11,918
New +$3.26M 0.03% 268
2025
Q3
– Sell
-2,064
Closed -$452K – 1230
2025
Q2
$452K Buy
+2,064
New +$441K ﹤0.01% 597
2024
Q4
– Sell
-33,631
Closed -$10.1M – 807
2024
Q3
$10.1M Buy
33,631
+24,214
+257% +$7.42M 0.22% 90
2024
Q2
$3.1M Buy
9,417
+5,491
+140% +$1.94M 0.06% 160
2024
Q1
$1.55M Sell
3,926
-17,005
-81% -$6.29M 0.03% 223
2023
Q4
$7.37M Buy
20,931
+14,871
+245% +$5.26M 0.19% 90
2023
Q3
$2.27M Buy
+6,060
New +$2.34M 0.06% 175
2023
Q2
– Sell
-29,300
Closed -$10.2M – 631
2023
Q1
$10.2M Buy
+29,300
New +$8.56M 0.2% 104
2022
Q4
– Sell
-13,983
Closed -$3.44M – 967
2022
Q3
$3.44M Buy
+13,983
New +$4.26M 0.05% 443
2020
Q1
– Sell
-2,364
Closed -$355K – 665
2019
Q4
$355K Buy
+2,364
New +$344K 0.01% 400
2019
Q2
– Sell
-2,358
Closed -$260K – 559
2019
Q1
$260K Buy
+2,358
New +$245K 0.01% 340
2017
Q2
– Sell
-8,802
Closed -$718K – 973
2017
Q1
$718K Buy
+8,802
New +$736K 0.01% 395

Other funds holding WST

Magnetar Financial's WST Position: Q1 2026 in Review

Magnetar Financial sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 11,918 shares — an estimated $3.28M sold.

Magnetar Financial first reported a position in WST in Q1 2017 and held it in 12 quarters. The position peaked at $10.2M in Q1 2023. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Magnetar Financial reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Magnetar Financial sold 11,918 West Pharmaceutical shares in Q1 2026, an estimated $3.28M.
  • Magnetar Financial first reported a position in West Pharmaceutical in Q1 2017 and held it in 12 quarters.
  • Magnetar Financial's West Pharmaceutical position peaked at $10.2M in Q1 2023.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.